News for 'Dr Reddy'

Should Children Get COVID-19 Vaccine?

Should Children Get COVID-19 Vaccine?

Rediff.com8 Sep 2021

Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.

Should you invest in MNC pharma?

Should you invest in MNC pharma?

Rediff.com25 Oct 2004

Telangana to celebrate 10th formation day over 21 days

Telangana to celebrate 10th formation day over 21 days

Rediff.com2 Jun 2023

President Droupadi Murmu and Prime Minister Narendra Modi greeted the people of Telangana on the 10th State Formation Day while state Governor Tamilisai Soundararajan, Chief Minister K Chandrasekhar Rao and Union Minister for Tourism G Kishan Reddy separately hoisted the national flag on the occasion here on Friday.

Ranbaxy tops in patents filing in developing world

Ranbaxy tops in patents filing in developing world

Rediff.com17 Mar 2003

Domestic pharma giant Ranbaxy Laboratories Limited has topped the list of patent filers in the area of drug applications from the Third World countries last year with 64 new formulations.\n\n\n\n

Generics: Long drawn journey!

Generics: Long drawn journey!

Rediff.com19 Aug 2004

US markets have been very lucrative for the Indian pharma companies and many companies such as Ranbaxy and Dr Reddy's capitalised on this opportunity.

Sensex up 23 points at 13,703

Sensex up 23 points at 13,703

Rediff.com24 Nov 2006

The Sensex closed up 22.50 points or 0.16% at 13,703.33, and the Nifty up 5.40 points or 0.14% at 3950.85.

Sensex down 76 points at 13,429

Sensex down 76 points at 13,429

Rediff.com17 Nov 2006

The markets opened in the positive terrain but slipped and are trading flat as selling was seen in banking and pharma stocks

Sensex crashes by 135 points at close

Sensex crashes by 135 points at close

Rediff.com23 Aug 2005

The Sensex slipped into negative territory, after opening 14 points up at 7,765.

Pharma industry's most wanted men

Pharma industry's most wanted men

Rediff.com29 Apr 2004

India Inc braces for fallout of Russia-Ukraine crisis

India Inc braces for fallout of Russia-Ukraine crisis

Rediff.com23 Feb 2022

Stocks of Indian companies with exposure to Europe fell on Tuesday amid concerns about the impact on their sales in case the Russia-Ukraine crisis worsens and the US and its allies impose economic sanctions on Russia. While top conglomerates, including Reliance Industries, the Tata group, and Aditya Birla Group, said they did not have any significant exposure to Russia, executives of some of the oil and gas, pharmaceutical, and tea companies said they were monitoring the situation closely as they earned substantial income from the region. Russian President Vladimir Putin on Monday ordered troops into two breakaway regions of eastern Ukraine after announcing that Russia would recognise their independence.

US dream sours for Indian drug firms

US dream sours for Indian drug firms

Rediff.com19 Jul 2005

These Scientists Shaped India

These Scientists Shaped India

Rediff.com15 Aug 2023

I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.

1st time Sensex gains 100pts in 4 straight session

1st time Sensex gains 100pts in 4 straight session

Rediff.com27 Jul 2006

The markets opened strong on F&O expiry today despite some mixed global cues

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Rediff.com7 Aug 2023

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Big companies like Cipla and Alkem have a significant presence in the segment but recently, players like Torrent Pharmaceuticals and Dr Reddy's Laboratories (DRL) have also entered this market. What is driving big pharma's focus on trade generics? The volume growth in the Indian Pharma Market (IPM) has come down from 5.6 per cent in FY16 to 0.1 per cent in FY23.

Community transmission of COVID-19 well-established: Experts

Community transmission of COVID-19 well-established: Experts

Rediff.com1 Jun 2020

"It is unrealistic to expect that COVID-19 pandemic can be eliminated at this stage given that community transmission is already well-established across large sections or sub-populations in the country," the report said.

Sensex gains 176 points to 12,219

Sensex gains 176 points to 12,219

Rediff.com2 May 2006

The Nifty gained 47 points to close at 3,605.\n\n

Markets end marginally higher even as Fed rate hike looms

Markets end marginally higher even as Fed rate hike looms

Rediff.com14 Jun 2017

Nifty PSU Bank index gained 1% led by Allahabad Bank, Andhra Bank, Syndicate Bank and IDBI Bank

Trading strategy for April 29

Trading strategy for April 29

Rediff.com28 Apr 2003

Cipla recalls asthma drugs in US

Cipla recalls asthma drugs in US

Rediff.com21 May 2015

Cipla is recalling the drug for failed impurities and degradation specifications.

India's pharma industry likely to take 5-6% price hikes this year

India's pharma industry likely to take 5-6% price hikes this year

Rediff.com6 Sep 2023

Notwithstanding the fact that the country's pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders predict that the overall domestic pharma industry will only witness a price hike of 5-6 per cent. This is attributed to higher competitive intensity in the market. Krishnakumar V, executive director and chief operating officer (CEO) of Eris Lifesciences, a domestic-focused pharma company, noted that the NLEM segment experienced growth suppression of around 150 basis points due to price reductions during the January to July period this year.

AWS to invest $4.4 bn in India by 2030 through new Hyderabad region service

AWS to invest $4.4 bn in India by 2030 through new Hyderabad region service

Rediff.com23 Nov 2022

Amazon Web Services (AWS) will invest nearly $4.4 billion (Rs 36,000 crore) in India by 2030 and support more than 48,000 jobs externally through a new regional service launched on Tuesday, said the on-demand Cloud computing company. AWS Asia Pacific (Hyderabad) is the company's second infrastructure region in India, six years after it opened its first Cloud region in Mumbai in 2016. The Hyderabad region will give customers access to AWS technologies for data analytics, security, machine learning, and artificial intelligence.

Pharma power

Pharma power

Rediff.com26 Jun 2004

Sensex gains 94 points to 8,284

Sensex gains 94 points to 8,284

Rediff.com15 Sep 2005

The Sensex opened past the 8,200-mark at 8,208 as against Wednesday's close of 8,189 and later rallied smartly to a high of 8,252.

Sensex gains 34 points at close

Sensex gains 34 points at close

Rediff.com1 Aug 2005

With rains once again lashing Mumbai, the Sensex opened weak and is now down 20 points at 7616. Nifty is down 8 points at 2304.

Constitution row: Cong to turn up heat on KCR, to lodge complaints

Constitution row: Cong to turn up heat on KCR, to lodge complaints

Rediff.com5 Feb 2022

Reddy stated that KCR's statement on proposing a new constitution is an extension of the idea of the BJP.

Investor wealth jumps over Rs 12.31 lakh cr in 3 days

Investor wealth jumps over Rs 12.31 lakh cr in 3 days

Rediff.com3 Feb 2021

Investor wealth has jumped by over Rs 12.31 lakh crore in three days, taking the market capitalisation of all BSE-listed companies to a record Rs 198.43 lakh crore on Wednesday as equities continued their Budget-driven rally. The BSE benchmark Sensex closed above the historic 50,000 mark for the first time ever on Wednesday. The 30-share benchmark closed with a gain of 458.03 points or 0.92 per cent at 50,255.75. During the day, it zoomed 728.67 points to its lifetime high of 50,526.39. In three trading days, the benchmark has gained 3,969.98 points or 8.57 per cent.

Sensex gains 12 points at close

Sensex gains 12 points at close

Rediff.com27 Oct 2004

The Sensex opened marginally (six points) higher at 5,657. Weakness in Infosys and Dr.Reddy's in early morning deals pulled down the index to an intra-day low of 5,623.\n\n

3 myths about mutual funds

3 myths about mutual funds

Rediff.com12 Oct 2004

Being a successful investor is all about making the most prudent investment decisions, even if they are dull and boring.

Sensex sheds 168 points to 14,041

Sensex sheds 168 points to 14,041

Rediff.com23 Jan 2007

The index touched a low of 14,026, before settling with a loss of 168 points at 14,041.

After showing signs of recovery, pharma sales dip in July

After showing signs of recovery, pharma sales dip in July

Rediff.com11 Aug 2020

Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed.

Top 5 Moments in India-Australia T20 History

Top 5 Moments in India-Australia T20 History

Rediff.com22 Nov 2023

Let's delve into India's T20I track record against Australia

VAT fear may hurt Indian drug firms' March sales

VAT fear may hurt Indian drug firms' March sales

Rediff.com3 Apr 2003

Indian drugmakers' domestic sales of ready-to-take medicines in January-March could be lower than expected as distributors suspended stocking in anticipation of a new value-added tax system coming into force, analysts and industry members said.\n\n\n\n

Ranbaxy's pill is far sweeter

Ranbaxy's pill is far sweeter

Rediff.com12 Aug 2004

Ram Charan, Upasana Have A Daughter!

Ram Charan, Upasana Have A Daughter!

Rediff.com20 Jun 2023

On June 19 evening, Upasana was admitted to the Apollo Hospital in Jubilee Hills, Hyderabad.

Sensex up 44 points at 13,469

Sensex up 44 points at 13,469

Rediff.com15 Nov 2006

The markets opened in the positive terrain after seeing a flat close yesterday

Sensex sheds 25 points at close

Sensex sheds 25 points at close

Rediff.com18 Oct 2006

The markets opened flat on the back of weak Asian and US cues

4 more Covid vaccines in pipeline: Health ministry

4 more Covid vaccines in pipeline: Health ministry

Rediff.com12 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.